AuntMinnie

SEPTEMBER 30, 2024

A radiopharmaceutical therapy that lengthens progression-free survival for patients with neuroendocrine cancer could help treat meningioma sufferers, according to research presented at the American Society for Radiation Oncology (ASTRO) meeting. Nearly 80% of patients in our study were progression-free after six months," he said.

Radiation Oncology 120

Radiation Oncology Radiopharmaceuticals Radiation Clinic 120

AuntMinnie

APRIL 4, 2024

Life Molecular Imaging (LMI) and Sofie Biosciences have begun offering the Neuraceq ( florbetaben F-18) PET radiotracer produced at Sofie's radiopharmaceutical manufacturing site in Cleveland, Ohio. With this expansion, LMI continues driving commercial sales of Neuraceq around the U.S.

Radiopharmaceuticals 92

Radiopharmaceuticals Imaging Disease Diagnostic 92

Imaging Technology

MAY 14, 2024

milla1cf Tue, 05/14/2024 - 12:45 May 14, 2024 — University Hospitals (UH) and Siemens Healthineers announce a 10-year strategic alliance that builds on their 40-year history of clinical and research collaboration. tesla and 3T scanners. Separately, Varian, a Siemens Healthineers company, will provide linear accelerators.

Hospital 116

Hospital Magnetic Resonance Imaging Radiopharmaceuticals Disease 116

AuntMinnie

DECEMBER 8, 2023

Organizing pneumonia can hide underlying lung cancers in up to 10% of cases, and repeat imaging in the form of PET/CT -- and additional biopsy -- should be considered in patients with high clinical suspicion of malignancy, researchers have reported. Kim discussed a case that demonstrated how additional biopsy proved necessary.

Imaging 123

Imaging Radiopharmaceuticals Disease Diagnose 123

Imaging Technology

APRIL 5, 2024

milla1cf Fri, 04/05/2024 - 11:31 April 5, 2024 — RLS Radiopharmacies , America’s only Joint Commission-accredited radiopharmacy network, today announced it has expanded its radiopharmaceutical contract development and manufacturing (rCDMO) capabilities by entering into a strategic agreement with global isotope technology leader Eckert & Ziegler.

Radiopharmaceuticals 52

Radiopharmaceuticals Radiation Oncology Radiation Quality and Compliance 52

Imaging Technology

AUGUST 31, 2023

milla1cf Thu, 08/31/2023 - 15:50 August 31, 2023 — NorthStar Medical Radioisotopes , LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals, and Curadh MTR Inc. Ac-225 for use in radiopharmaceutical therapy (RPT). actinium-225 (Ac-225). “As a company at the forefront of U.S.

Medical 98

Medical Radiopharmaceuticals Pharmaceutical Radiation 98

Imaging Technology

OCTOBER 21, 2024

21, 2024 — Siemens Healthineers recently received Food and Drug Administration clearance for two new features in its syngo.PET Cortical Analysis software application that use positron emission tomography (PET) to measure protein deposits in the brain associated with Alzheimer’s disease. tim.hodson Mon, 10/21/2024 - 10:17 Oct.

Disease 52

Disease Radiopharmaceuticals PET Scan Clinic 52

Imaging Technology

MAY 23, 2023

milla1cf Tue, 05/23/2023 - 11:36 May 23, 2023 — More than 9 in 10 radiation oncologists report that their practices face clinical staff shortages , according to a new national survey from the American Society for Radiation Oncology ( ASTRO ). Radiation oncologists from across the country are in Washington, D.C. in the past three decades.

Radiation Oncology 96

Radiation Oncology Radiation Clinic Medicare 96

AuntMinnie

MARCH 25, 2024

PET/CT is poised to become a key tool for imaging the coronary arteries – a clinical imaging exam that can reveal early warning signs of fatal conditions when patients present with symptoms of chest pain, experts say. Coronary artery disease (CAD) is the leading cause of mortality in the U.S. The game-changer could be the pending U.S.

Nuclear Medicine 128

Nuclear Medicine Radiopharmaceuticals Disease Radiation 128

Imaging Technology

JANUARY 12, 2024

“We are grateful that CMS recognizes the potential of our SCINTIX therapy for patients with all stages of indicated cancers and, with this decision, has addressed provider payment as a barrier to clinical adoption,” continued Powell. Patient treatments also began at several clinical sites in 2023. 1, 2024, to describe SCINTIX therapy.

Radiopharmaceuticals 105

Radiopharmaceuticals Radiation Medicare Clinic 105

Imaging Technology

JULY 28, 2023

We believe it further validates the clinical utility of POSLUMA in patients with newly diagnosed or recurrent prostate cancer, and can help expand patient access. FDA, as well as on the Phase 3 clinical trial results published recently in the Journal of Urology and European Urology. Chief Executive Officer of the Company. “We

Diagnostic 98

Diagnostic Clinic Radiopharmaceuticals Radiation 98

Imaging Technology

JANUARY 5, 2024

milla1cf Fri, 01/05/2024 - 11:32 January 5, 2024 — NorthStar Medical Radioisotopes, LLC , a global innovator in development, production and commercialization of radiopharmaceuticals used to detect and treat cancer and other serious diseases, and Curadh MTR Inc. Chief Executive Officer of NorthStar Medical Radioisotopes.

Radiopharmaceuticals 52

Radiopharmaceuticals Medical Nuclear Medicine Pharmaceutical 52

AuntMinnie

FEBRUARY 12, 2024

Chinese clinicians have provided evidence in a “real-world study” that shows amyloid PET imaging is effective for diagnosing and managing patients with Alzheimer’s disease, according to a study published February 8 in Alzheimer’s and Dementia. The clinical utility of amyloid PET scans has been systematically studied in many other countries.

PET Scan 104

PET Scan Diagnose Disease Radiopharmaceuticals 104

Imaging Technology

APRIL 3, 2023

Mr. Merrick continued, “Demand for therapeutic radiopharmaceuticals is increasing rapidly. NorthStar has further deepened and broadened our business platform with the recent establishment of a full-scale radiopharmaceutical CDMO/CMO services unit. Ac-225 using advanced, environmentally preferable electron accelerator technology.

Medical 98

Medical Radiopharmaceuticals Pharmaceutical Radiation 98

Imaging Technology

JULY 5, 2023

Ac-225 is a high energy alpha-emitting radioisotope of increasing interest for clinical studies investigating the use of targeted radiopharmaceutical therapy, which combines select molecules with therapeutic radioisotopes to directly target and deliver therapeutic doses of radiation to destroy cancer cells in patients with serious disease.

Medical 92

Medical Radiopharmaceuticals Pharmaceutical Radiation 92

AuntMinnie

JUNE 3, 2024

With therapeutic radiopharmaceuticals coming to market quickly and available to smaller institutions around the U.S., My vision of a theranostic center includes a flagship facility that has a PET/CT scanner, a SPECT/CT scanner, and then multiple rooms for infusions of radiopharmaceuticals," Siegel explained.

Nuclear Medicine 106

Nuclear Medicine Radiopharmaceuticals Radiation Radiation Oncology 106

Imaging Technology

AUGUST 28, 2023

The companies will work together to increase near-term production of 225Ac [1] to support ongoing clinical trials and to ensure the large-scale supply of the radioisotope in the long term, addressing growing global demand. Whilst there is high demand, there is a scarcity of 225Ac.

Radiopharmaceuticals 98

Radiopharmaceuticals Pharmaceutical Medical Clinic 98

Imaging Technology

AUGUST 23, 2023

SCINTIX therapy is a cutting-edge radiopharmaceutical-directed treatment applicable for early and late-stage cancers that uses the individual biology of each tumor to drive its own treatment. “We founder and CTO of RefleXion. “We founder and CTO of RefleXion.“We

Radiopharmaceuticals 98

Radiopharmaceuticals Disease Radiation Clinic 98

AuntMinnie

JANUARY 19, 2024

more than 6 million Americans have Alzheimer's disease, a debilitating and far-reaching disease that accounts for 60% to 80% of dementia cases, and by 2050, this number is projected to rise to nearly 13 million, according to Alzheimer’s Disease International. The disease affects memory, thinking, and behavior. In the U.S.,

Disease 52

Disease Medicare Imaging PET Scan 52

AuntMinnie

OCTOBER 25, 2024

Most Influential Radiology Researcher Erik Middlebrooks, MD, Mayo Clinic, Jacksonville, FL Erik Middlebrooks, MD. One of this year's nominations for Most Influential Radiology Researcher is Erik Middlebrooks, MD, of the Mayo Clinic in Jacksonville, FL. But we're still just scratching the surface."

Nuclear Medicine 143

Nuclear Medicine Education Radiology Technologist Radiation Science 143

Imaging Technology

JANUARY 23, 2024

The machine will be used primarily for the manufacture of Strontium-82 for use in the diagnosis of cardiovascular disease, as well as for production of Germanium-68 for use in positron emission tomography (PET) imaging. To date, six Cyclone® 70 MeV machines and over 35 cyclotrons of 30 MeV have been installed worldwide.

Radiopharmaceuticals 111

Radiopharmaceuticals Disease Diagnostic Clinic 111

Imaging Technology

JULY 5, 2024

mtaschetta-millane Fri, 07/05/2024 - 06:00 July 5, 2024 — Lantheus Holdings, Inc. ,

Diagnostic 105

Diagnostic Radiopharmaceuticals Disease IT 105

Imaging Technology

APRIL 2, 2024

The availability of these offerings – including the MIM SurePlan and MIM Symphony families, MIM Maestro, MIM Encore, and more – is in alignment with GE HealthCare’s precision care strategy, which aims to deliver innovative digital solutions across care pathways for more precise, connected, and efficient care across disease states. "We

Healthcare 105

Healthcare Healthcare Radiation Oncology Magnetic Resonance Imaging 105

Imaging Technology

MAY 30, 2023

milla1cf Tue, 05/30/2023 - 19:49 May 30, 2023 — Blue Earth Diagnostics , a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals , today announced U.S. In clinical trials , the safety of POSLUMA was evaluated in 747 patients with initial or recurrent prostate cancer.

Diagnostic 97

Diagnostic Imaging Radiopharmaceuticals Diagnostic Imaging 97

AuntMinnie

NOVEMBER 21, 2024

Topics cover the safety and effectiveness of lutetium-177 (Lu-177) prostate-specific membrane antigen (PSMA)-617 (Pluvicto) in patients with prostate cancer to its cost, as well as whether PSMA-PET radiotracers are equally effective for detecting the disease. AI studies in nuclear medicine appear to be picking up steam as well. 8:40 a.m. |

Nuclear Medicine 106

Nuclear Medicine Imaging Radiopharmaceuticals Disease 106

Imaging Technology

MAY 2, 2023

milla1cf Tue, 05/02/2023 - 23:50 May 2, 2023 — Blue Earth Diagnostics , a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today announced additional results from its completed Phase 3 SPOTLIGHT trial of 18F-rhPSMA-7.3 on behalf of the SPOTLIGHT Study Group. 18F-rhPSMA-7.3

Diagnostic 98

Diagnostic Radiopharmaceuticals Imaging Radiation 98

AuntMinnie

OCTOBER 2, 2024

Ultrasound model predicts liver disease progression. Assessment of Claimant, Clinical, and Financial Characteristics of Teleradiology Medical Malpractice Cases. Commercially Available Chest Radiograph AI Tools for Detecting Airspace Disease, Pneumothorax, and Pleural Effusion. SPECT/CT reveals heart’s response to tafamidis.

Digital Imaging and Communications in Medicine 144

Digital Imaging and Communications in Medicine X-ray MRI Hospital 144

AuntMinnie

NOVEMBER 12, 2024

Middlebrooks, MD, Mayo Clinic, Jacksonville, FL Erik H. Middlebrooks, MD, of the Mayo Clinic in Jacksonville, FL. Importantly, we are gaining deeper insights into disease processes themselves, which enhances our ability to diagnose and potentially treat conditions that were previously beyond our reach." Middlebrooks, MD.

Radiologist 144

Radiologist Education Clinic Radiology 144

AuntMinnie

JANUARY 30, 2024

Efforts to bring quantitative MRI analysis into clinical practice received a boost with the availability of two new Category III Current Procedural Terminology (CPT) codes for brain MRI. The timing of the new codes dovetails with advances in neuroimaging, such as in the assessment of white-matter diseases.

MRI 104

MRI Radiopharmaceuticals Disease Imaging 104

AuntMinnie

AUGUST 2, 2024

CereMark Pharma, a radiopharmaceutical company focused on neurodegenerative diseases, is planning a phase III clinical trial later this year to investigate the novel PET imaging agent F-18 flornaptitril. CereMark recently announced a collaboration with Hall of Fame Health to support its upcoming clinical studies.

Radiopharmaceuticals 52

Radiopharmaceuticals Disease Clinic IT 52

AuntMinnie

AUGUST 22, 2024

Food and Drug Administration (FDA) has granted Clarity Pharmaceuticals fast-track designation for its copper-64 (Cu-64) sarcophagine (SAR) bisPSMA radiopharmaceutical.

Pharmaceutical 52

Pharmaceutical Radiopharmaceuticals Disease Clinic 52

Imaging Technology

JUNE 26, 2023

For more than two decades, Mahmood has been involved in the development and implementation of new imaging methods for the examination of disease processes, with a focus on translatable technology and early therapeutic response assessment. Mahmood was also a Highlights lecturer at the SNMMI Annual Meeting.

Nuclear Medicine 98

Nuclear Medicine Education Radiopharmaceuticals Hospital 98

Imaging Technology

JULY 20, 2023

Dr. Keole is a radiation oncologist at the Mayo Clinic in Scottsdale, Arizona and also sees patients at Phoenix Children’s Hospital. Excellent clinical care can be provided in any practice setting, and innovations in how we treat cancer can be achieved in many different environments,” he said. “I

Radiation Oncology 98

Radiation Oncology Radiation Government Community Practice 98

AuntMinnie

APRIL 4, 2024

A decade ago, only a few radiopharmaceutical agents were used to help treat cancer patients. They're also mindful of the multiple dedicated teams required to build a theranostics clinic properly. How many centers have the physical space in their nuclear medicine departments to treat a disease as common as prostate cancer?"

Nuclear Medicine 89

Nuclear Medicine Radiation Oncology Nursing Radiation 89

Imaging Technology

SEPTEMBER 27, 2023

PET imaging with POSLUMA reveals clinical information crucial to decision-making for men with prostate cancer, and we are excited to share further information with the radiation oncology community at ASTRO 2023,” said David E. “PET Clinical correlation, which may include histopathological evaluation, is recommended. Gauden , D.Phil.,

Diagnostic 105

Diagnostic Radiation Oncology Radiation Clinic 105

AuntMinnie

AUGUST 20, 2024

Life Molecular Imaging and PharmaLogic Holdings have inked a partnership and licensing agreement to provide and distribute the imaging agent Neuraceq from PharmaLogic's radiopharmaceutical manufacturing site near Denver, CO. Neuraceq is a diagnostic agent cleared by the U.S. Food and Drug Administration (FDA) for PET imaging of the brain.

Radiopharmaceuticals 40

Radiopharmaceuticals Disease Diagnostic Clinic 40

Imaging Technology

JUNE 20, 2024

Additionally, the Omni platform is scalable, allowing radiology departments and healthcare facilities to upgrade the hardware and add service lines to help meet growing demand as well as optimize clinical capabilities, ensure access to the latest technology, and accommodate evolving community needs for many years to come.

Healthcare 104

Healthcare Healthcare Nuclear Medicine Computed Tomography 104